NCT00246974 - Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT | Biotech Hunter

Enrollment

125

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2007

Conditions

Bladder Cancer

Interventions

DRUG

Gemcitabine

intravenous

DRUG

Cisplatin

intravenous

DRUG

Gefitinib

oral

Trial Locations (14)

Research Site, Aachen

Research Site, Augsburg

Research Site, Berlin

Research Site, Dresden

Research Site, Freiburg im Breisgau

Research Site, Halle

Research Site, Hamburg

Research Site, Hanover

Research Site, Kassel

Research Site, Mainz

Research Site, Mannheim

Research Site, Münster

Research Site, Tübingen

Research Site, Ulm